Cardea Bio (formerly: Nanomedical Diagnostics) and Nanosens Innovations have joined forces to accelerate the development of the Genome Sensor: the world's first DNA search engine that runs on CRISPR-Chip technology.
Cardea has announced the finalization of their merger-acquisition of Nanosens Innovations, the creators of CRISPR-Chip. Cardea first came out with the news of the proposed merger in September, along with the announcement of their Early Access Program for the Genome Sensor. Built with CRISPR-Chip technology, the Genome Sensor is the world’s first DNA search engine. It can google genomes to detect genetic mutations and variations.